Factor | All patients n = 419 | |||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
Age in years | ||||||
≤ 40 vs. ≥41 | 4.36 | 1.67–11.39 | 0.003 | |||
≤ 50 vs. ≥51 | 2.97 | 1.19–7.42 | 0.02 | 2.73 | 1.01–7.40 | 0.047 |
Pathological T stage | ||||||
0, Tis, 1 vs. 2–4 | 2.19 | 0.72–6.64 | 0.17 | 2.69 | 0.88–8.22 | 0.08 |
Histology | ||||||
IDC vs. others | 0.93 | 0.23–3.84 | 0.92 | |||
Histological grade | ||||||
1 vs. 2 | 0.72 | 0.25–2.13 | 0.56 | |||
1 vs. 3 | 0.52 | 0.18–1.51 | 0.23 | |||
Number of positive nodes | ||||||
0 vs. 1–3 | 0.96 | 0.52–1.79 | 0.91 | |||
0 vs. ≥4 | 1.99 | 0.25–15.85 | 0.52 | |||
Hormonal receptor status | ||||||
Negative vs. positive | 1.09 | 0.67–1.77 | 0.74 | |||
Chemotherapy | ||||||
No vs. yes | 0.77 | 0.50–1.19 | 0.24 | 0.79 | 0.49–1.27 | 0.33 |
Endocrine therapy | ||||||
No vs. yes | 0.71 | 0.24–2.12 | 0.54 |